SC
Stempoint Capital Portfolio holdings
AUM
$311M
This Quarter Return
+23.56%
1 Year Return
+15.22%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$348M
AUM Growth
–
Cap. Flow
+$348M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
42.53%
Holding
63
New
55
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Roivant Sciences
ROIV
|
$24.4M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
$23.7M |
| 3 |
Arcellx
ACLX
|
$17.4M |
| 4 |
Merus
MRUS
|
$13.8M |
| 5 |
Immunovant
IMVT
|
$13.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 98.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Amylyx Pharmaceuticals
AMLX
$873M
| $1.23M | 0.33% |
+83,381
| New | +$1.23M |
|
52
Shattuck Labs
STTK
$47.3M
| $1.05M | 0.28% |
+147,752
| New | +$1.05M |
|
53
AnaptysBio
ANAB
$580M
| $964K | 0.26% |
+45,000
| New | +$964K |
|
54
Tarsus Pharmaceuticals
TARS
$2.49B
| $628K | 0.17% |
+30,990
| New | +$628K |
|
|
CRGX
55
DELISTED
CARGO Therapeutics
CRGX
| $622K | 0.17% |
+26,875
| New | +$622K |
|
56
argenx
ARGX
$42.8B
| – | – |
0
| – | – |
|
57
ARK Genomic Revolution ETF
ARKG
$1.05B
| – | – |
0
| – | – |
|
58
iShares Biotechnology ETF
IBB
$5.69B
| – | – |
0
| – | – |
|
59
iShares Russell 2000 ETF
IWM
$66.5B
| – | – |
0
| – | – |
|
60
Jasper Therapeutics
JSPR
$44.7M
| – | – |
0
| – | – |
|
61
Invesco QQQ Trust
QQQ
$360B
| – | – |
0
| – | – |
|
62
Teva Pharmaceuticals
TEVA
$21.5B
| – | – |
0
| – | – |
|
|
MOR
63
DELISTED
MorphoSys AG American Depositary Shares
MOR
| – | – |
0
| – | – |
|